Literature DB >> 21068283

Human neurocysticercosis: comparison of different diagnostic tests using cerebrospinal fluid.

Lorraine Michelet1, Agnès Fleury, Edda Sciutto, Eric Kendjo, Gladis Fragoso, Luc Paris, Bernard Bouteille.   

Abstract

Neurocysticercosis (NC), caused by the larval stage of Taenia solium, is one of the most common parasitic diseases of the central nervous system. The diagnosis of NC is mostly based on costly brain neuroimaging (computed tomography and/or nuclear magnetic resonance), which is rarely accessible in most affected areas. The most sensitive and specific tools for NC diagnosis are imagery techniques. The identification of specific antibodies and antigens is currently used only to support NC diagnosis due to their limited specificity and sensitivity. This study was performed to compare immunodiagnostic assays (antibody detection by enzyme-linked immunosorbent assay [ELISA] and enzyme-linked immunoelectrotransfer blotting [EITB] and HP10 antigen detection by ELISA) with the detection of parasite DNA by PCR amplification of a repetitive element of the parasite genome in the cerebrospinal fluid (CSF) of 121 radiologically and clinically characterized NC patients. Patients were divided into six groups according to the stage of the parasites and their localization. The CSF cellularity of each patient was also recorded. When all patients were considered, PCR exhibited the highest sensitivity (95.9%) and variable specificity (80% or 100%) depending on the controls used. The sensitivities of antibody detection by ELISA and EITB were not significantly different, and ELISA identified HP10 antigen mostly when vesicular cysticerci were located in the subarachnoideal basal cisterns. These results can help in the selection of different individual assays or combinations of assays to be used in NC diagnosis according to different requirements.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21068283      PMCID: PMC3020422          DOI: 10.1128/JCM.01554-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  43 in total

Review 1.  Intracranial cysts: radiologic-pathologic correlation and imaging approach.

Authors:  Anne G Osborn; Michael T Preece
Journal:  Radiology       Date:  2006-06       Impact factor: 11.105

2.  Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis.

Authors:  Carolina R Almeida; Elida P Ojopi; Cáris M Nunes; Luis R Machado; Osvaldo M Takayanagui; José A Livramento; Ronaldo Abraham; Wagner F Gattaz; Adelaide J Vaz; Emmanuel Dias-Neto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-07-10       Impact factor: 5.270

Review 3.  New concepts in the diagnosis and management of neurocysticercosis (Taenia solium).

Authors:  Hector H Garcia; Oscar H Del Brutto; Theodore E Nash; A Clinton White; Victor C W Tsang; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2005-01       Impact factor: 2.345

4.  Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up.

Authors:  Raúl J Bobes; Marisela Hernández; Carlos Márquez; Gladis Fragoso; Esperanza García; R Michael E Parkhouse; Leslie J S Harrison; Edda Sciutto; Agnès Fleury
Journal:  Trop Med Int Health       Date:  2006-06       Impact factor: 2.622

Review 5.  Neurocysticercosis: updated concepts about an old disease.

Authors:  Hector H Garcia; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2005-10       Impact factor: 44.182

6.  Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis.

Authors:  A Fleury; M Hernández; M Avila; G Cárdenas; R J Bobes; M Huerta; G Fragoso; L Uribe-Campero; L J S Harrison; R M E Parkhouse; E Sciutto
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-02       Impact factor: 10.154

7.  An epidemiological study of familial neurocysticercosis in an endemic Mexican community.

Authors:  A Fleury; J Morales; R J Bobes; M Dumas; O Yánez; J Piña; R Carrillo-Mezo; J J Martínez; G Fragoso; A Dessein; C Larralde; E Sciutto
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-11-28       Impact factor: 2.184

8.  Serodiagnosis of neurocysticercosis using synthetic 8-kD proteins: comparison of assay formats.

Authors:  Christina M Scheel; Azra Khan; Kathy Hancock; Hector H Garcia; Armando E Gonzalez; Robert H Gilman; Victor C W Tsang
Journal:  Am J Trop Med Hyg       Date:  2005-10       Impact factor: 2.345

9.  Neurocysticercosis: detection of Taenia solium DNA in human cerebrospinal fluid using a semi-nested PCR based on HDP2.

Authors:  M Hernández; L M Gonzalez; A Fleury; B Saenz; R M E Parkhouse; L J S Harrison; T Garate; E Sciutto
Journal:  Ann Trop Med Parasitol       Date:  2008-06

Review 10.  Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review.

Authors:  Tu Luong Mac; Duc-Si Tran; Fabrice Quet; Peter Odermatt; Pierre-Marie Preux; Chong Tin Tan
Journal:  Lancet Neurol       Date:  2007-06       Impact factor: 44.182

View more
  27 in total

Review 1.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

Review 2.  Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.

Authors:  Jaco J Verweij; C Rune Stensvold
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

3.  Neurocysticercosis in Bhutan: a cross-sectional study in people with epilepsy.

Authors:  Kate Brizzi; Sonam Pelden; Tshokey Tshokey; Damber K Nirola; Megan B Diamond; Joshua P Klein; Lhab Tshering; Sonam Deki; Dechen Nidup; Veronica Bruno; Pierre Dorny; Hector Hugo Garcia; Farrah J Mateen
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-09       Impact factor: 2.184

Review 4.  Pediatric neurocysticercosis.

Authors:  Ricardo Santos de Oliveira; Dinark Conceição Viana; Benedicto Oscar Colli; Vedantam Rajshekhar; José Francisco Manganelli Salomão
Journal:  Childs Nerv Syst       Date:  2018-07-09       Impact factor: 1.475

5.  Immunodiagnosis of human neurocysticercosis: comparative performance of serum diagnostic tests in Mexico.

Authors:  Marisela Hernández; Osvaldo-Germán Astudillo; Gustavo Diego; Jorge-Luis de-la-Rosa-Arana; Antonio Meza-Lucas; Ricardo García-Rodea; Matthew-L Romo; Andrea Toledo; R-Michael-E Parkhouse; Teresa Garate; Edda Sciutto; Agnès Fleury
Journal:  Parasitol Res       Date:  2019-08-15       Impact factor: 2.289

6.  Neurocysticercosis in immigrant populations.

Authors:  Hector H Garcia
Journal:  J Travel Med       Date:  2012 Mar-Apr       Impact factor: 8.490

7.  Confirmation and follow-up of neurocysticercosis by real-time PCR in cerebrospinal fluid samples of patients living in France.

Authors:  H Yera; D Dupont; S Houze; M Ben M'rad; F Pilleux; A Sulahian; C Gatey; F Gay Andrieu; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

Review 8.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

9.  Serodiagnosis of human neurocysticercosis using antigenic components of Taenia solium metacestodes derived from the unbound fraction from jacalin affinity chromatography.

Authors:  Gleyce Alves Machado; Heliana Batista de Oliveira; Margareth Leitão Gennari-Cardoso; José Roberto Mineo; Julia Maria Costa-Cruz
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

Review 10.  Immunological and molecular diagnosis of cysticercosis.

Authors:  Silvia Rodriguez; Patricia Wilkins; Pierre Dorny
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.